INCY vs REGN: Which Stock is Better?
Side-by-side comparison of Incyte Corp and Regeneron Pharmaceuticals Inc in 2026
INCY
Incyte Corp
$98.07
REGN
Regeneron Pharmaceuticals Inc
$766.66
Key Metrics Comparison
| Metric | INCY | REGN | Winner |
|---|---|---|---|
| Market Cap | $19.91B | $81.05B | REGN |
| P/E Ratio | 15.61 | 18.48 | INCY |
| EPS (TTM) | $6.41 | $41.48 | REGN |
| Revenue Growth | 0.3% | 0.0% | INCY |
| Gross Margin | 52.9% | 44.6% | INCY |
Analyze INCY
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INCY or REGN a better investment?
Comparing INCY and REGN: Incyte Corp has a market cap of $19.91B while Regeneron Pharmaceuticals Inc has $81.05B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INCY and REGN?
INCY (Incyte Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INCY or REGN?
Based on P/E ratios, INCY trades at a lower multiple (15.6x vs 18.5x).
Which is growing faster: INCY or REGN?
INCY has higher revenue growth at 0.3% vs 0.0% for REGN.
Which company is more profitable: INCY or REGN?
Incyte Corp (INCY) has higher gross margins at 52.9% compared to 44.6% for REGN.
Which is the larger company: INCY or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $81.05B compared to $19.91B for INCY.
Should I buy INCY or REGN in 2026?
Both INCY and REGN have investment merit. INCY trades at $98.07 while REGN trades at $766.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INCY and REGN stock?
Key differences: Market Cap ($19.91B vs $81.05B), P/E Ratio (15.6x vs 18.5x), Revenue Growth (0.3% vs 0.0%), Gross Margin (52.9% vs 44.6%).